SUMMARY A subcutaneous ventricular catheter reservoir was inserted between the 16th and 28th (median 23rd) day of life in 13 premature infants (median birth weight 1220 g, range 780-2110) for the treatment of posthaemorrhagic hydrocephalus. Aspiration of cerebrospinal fluid (median 6 ml, range 1-15) one to four (median two) times a day for 6 to 90 (median 40) days controlled the hydrocephalus as judged by clinical and ultrasonographic criteria. There were no serious complications, except skin breakdown in one patient. Intracranial pressure measured in five patients through the reservoir showed the efficacy of the treatment, as well as the unreliability of clinical and ultrasonographic criteria in determining the amount of cerebrospinal fluid that should be aspirated daily.
Management of posthaemorrhagic hydrocephalus in premature infants during the first weeks of life is difficult because of the low body weight and the associated serious medical problems in these severely compromised patients. Surgical methods of controlling the intracranial pressure include serial lumbar punctures, 1-3 external ventricular drainage (usually through a subcutaneously tunnelled catheter)2 4 5 insertion of a ventriculoperitoneal shunt, 6 and placement of a subcutaneous ventricular catheter reservoir. 78 Since 1982 we have used a ventricular catheter with subcutaneous reservoir for the treatment of posthaemorrhagic hydrocephalus. In five of our patients the intracranial pressure was measured through the reservoir. The aim of this retrospective study was to assess the efficacy and the complications of this particular treatment, and of measuring intracranial pressure through the reservoir.
Patients and methods
Between 1982 and 1987 a ventricular catheter with a subcutaneous reservoir (Holter-Hausner International) was placed in each of 13 premature infants with posthaemorrhagic hydrocephalus ( In five patients a pressure transducer (Sensonor) was used to measure the intracranial pressure through the reservoir before and after aspiration of cerebrospinal fluid. An intracranial pressure of less than 6 mm Hg was considered to be normal. 9 For evaluation of the risk of the treatment the following possible complications were recorded: infection of the reservoir or sepsis (the presence of pathogens on culture of the cerebrospinal fluid), breakdown of the skin overlying the reservoir, intraventricular haemorrhage after aspiration of cerebrospinal fluid, leak from the reservoir, obstruction of the ventricular catheter, or low serum sodium (<135 mmol/l) or total protein (<40 g1l) concentrations.
Results
The essential data concerning the treatment are shown in table 1. Six patients weighed 1000 g or less at the time of insertion of the reservoir. Daily aspirations of the reservoir for more than 40 days were carried out in seven patients.
In all 13 patients, normal increase of occipitofrontal head circumference, unchanged or decreasing ventricular size, normal tension of the fontanelle, and normal position of cranial sutures were achieved. In 12 patients tapping was continued until a ventriculoatrial or ventriculoperitoneal shunt could be inserted with a low risk of complications. At the time of placement of the shunt, the median weight was 2320 g (range 1500-4500) and protein concentration in the cerebrospinal fluid was less than 1-5 g/l. In one patient the posthaemorrhagic hydrocephalus resolved spontaneously and no further treatment was necessary. None of the patients died.
Intracranial pressure was measured through the reservoir before and after aspiration of cerebrospinal fluid in five patients on 47 occasions (table 3) .
Aspiration of cerebrospinal fluid caused a decrease in intracranial pressure of between 2 and 11 (median 3) mm Hg. In fourteen of the 47 measurements before, and in two of the 47 measurements after aspiration of cerebrospinal fluid, the intracranial pressure was raised (that is, above 6 mm Hg). In three patients intracranial pressure was raised and returned to normal or was unchanged within the normal range; in another patient, the raised intracranial pressure did not decrease during the treatment, and subsequently a ventriculoatrial shunt was inserted. The clinical course and the ventricular size on ultrasound scans corresponded with the degree of intracranial pressure in these four patients. In one patient, however, intracranial pressure was raised to 14 mm Hg, although clinical signs and ventricular size on ultrasound scans did not show any signs of increasing intracranial pressure. This patient also had a ventriculoatrial shunt inserted.
The following complications occurred: skin breakdown (n= 1)-the reservoir was exchanged and prophylactic antibiotics were started; hyponatraemia (n=8), and hypoproteinaemia (n=2). In one patient erythrocytes were found in the cerebrospinal fluid during the fourth and fifth week after the reservoir had been inserted, but new intraparenchymal or intraventricular haemorrhages were not detectable on ultrasound examination. Neither a leak from the reservoir nor obstruction of the ventricular catheter was seen, nor did any infection occur that could be associated with the reservoir.
Discussion
The results of this study show that posthaemorrhagic hydrocephalus can be successfully treated with a subcutaneous ventricular catheter reservoir. Our 
